Cancer Research Institute (CRI) shared a following post on LinkedIn:

“Have you submitted your abstract for International Cancer Immunotherapy Conference (CICON24)?

CICON24’s intimate setting facilitates one-on-one interactions, fostering collaborations that will shape the future of cancer immunotherapy, and the submission portal for abstracts is open until June 3! Submit now to secure one of the limited oral presentation slots reserved for top-rated abstracts. Don’t miss this opportunity.”

Procced to the video.
Source: Cancer Research Institute/LinkedIn

About OncoDaily 

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.